Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy
Numerous epidemiological surveys may suggest that there is a relationship between chronic kidney disease (CKD) and asymptomatic hyperuricemia; at the same time there is growing evidence that elevated uric acid (UA) is the cause of kidney injury. The possible mechanisms of CKD in hyperuricemia are...
Main Author: | M. S. Eliseev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2018-04-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/810 |
Similar Items
-
Urate-lowering therapy and kidney function
by: M. S. Eliseev
Published: (2023-04-01) -
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
by: M S Eliseev, et al.
Published: (2019-05-01) -
Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications
by: M. S. Eliseev, et al.
Published: (2019-08-01) -
Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01) -
Urate-lowering therapy for heart failure
by: O. V. Zhelyabina, et al.
Published: (2019-09-01)